D-0219-2024 Class II Terminated
FDA drug recall D-0219-2024 was initiated by Dr. Reddy's Laboratories, Inc. on Dec 15, 2023 and is designated Class II. Reason for recall: Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules. The recall status is terminated (terminated Sep 16, 2024). Affected quantity: 8,280 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 17, 2024
- Initiation Date
- Dec 15, 2023
- Termination Date
- Sep 16, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8,280 bottles
Product description
Tacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally, 500 090, INDIA, NDC 55111-526-01
Reason for recall
Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.
Distribution pattern
US Nationwide.
Code information
Lot# C2307275; Exp. January 2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0219-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026